{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:21:48Z","timestamp":1789978908587,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003504","name":"University of the Western Cape","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003504","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Foundation of South Africa"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bmcl.2018.03.026","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:49:03Z","timestamp":1521074943000},"page":"1287-1291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Adamantane amine-linked chloroquinoline derivatives as chloroquine resistance modulating agents in Plasmodium falciparum"],"prefix":"10.1016","volume":"28","author":[{"given":"Opute M.","family":"Yvette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarel F.","family":"Malan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2018.03.026_b0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12936-016-1394-3","article-title":"Is Nigeria winning the battle against malaria? Prevalence, risk factors and KAP assessment among Hausa communities in Kano State","volume":"15","author":"Dawaki","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.bmcl.2018.03.026_b0010","unstructured":"World Health Organisation. World Malaria Report 2016. Geneva, Switzerland; 2016."},{"key":"10.1016\/j.bmcl.2018.03.026_b0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature03342","article-title":"The global distribution of clinical episodes of Plasmodium falciparum malaria","volume":"434","author":"Snow","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2018.03.026_b0020","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI33996","article-title":"Malaria: progress, perils, and prospects for eradication","volume":"118","author":"Greenwood","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmcl.2018.03.026_b0025","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature09442","article-title":"Origin of the human malaria parasite Plasmodium falciparum in gorillas","volume":"467","author":"Liu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2018.03.026_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2001.64.1","article-title":"The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden","volume":"64","author":"Breman","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bmcl.2018.03.026_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2004.71.2_suppl.0700001","article-title":"Conquering the intolerable burden of malaria: what\u2019s new, what\u2019s needed: a summary","volume":"71","author":"Breman","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bmcl.2018.03.026_b0040","first-page":"108","article-title":"Global malaria burden: socialomics implications","volume":"1","author":"Karunamoorthi","year":"2012","journal-title":"J Socialomics"},{"key":"10.1016\/j.bmcl.2018.03.026_b0045","unstructured":"World Health Organisation. Malaria Factsheets. <http:\/\/www.who.int\/mediacentre\/factsheets\/fs094\/en\/>; 2017 Accessed 13 March 2017."},{"key":"10.1016\/j.bmcl.2018.03.026_b0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1471-4922(02)02374-7","article-title":"Hot topic or hot air? Climate change and malaria resurgence in East African highlands","volume":"18","author":"Hay","year":"2002","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmcl.2018.03.026_b0055","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/415686a","article-title":"Medical need, scientific opportunity and the drive for antimalarial drugs","volume":"415","author":"Ridley","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2018.03.026_b0060","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/322858","article-title":"Chloroquine-resistant malaria","volume":"184","author":"Wellems","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2018.03.026_b0065","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMra043207","article-title":"Effectiveness of antimalarial drugs","volume":"352","author":"Baird","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2018.03.026_b0070","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0764-4469(98)80009-7","article-title":"Impact of chloroquine resistance on malaria mortality","volume":"321","author":"Trape","year":"1998","journal-title":"C R Acad Sci"},{"key":"10.1016\/j.bmcl.2018.03.026_b0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3201\/eid0201.960104","article-title":"Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks","volume":"2","author":"Zucker","year":"1996","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bmcl.2018.03.026_b0080","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmcl.2018.03.026_b0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1074045","article-title":"Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations","volume":"298","author":"Sidhu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2018.03.026_b0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2958.2005.04556.x","article-title":"Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance","volume":"56","author":"Bray","year":"2005","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmcl.2018.03.026_b0095","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.lfs.2003.10.003","article-title":"Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs","volume":"74","author":"Fitch","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.bmcl.2018.03.026_b0100","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.pt.2012.08.002","article-title":"PfCRT and its role in antimalarial drug resistance","volume":"28","author":"Ecker","year":"2012","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmcl.2018.03.026_b0105","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/ciw388","article-title":"Declining efficacy of artemisinin combination therapy against P. falciparum malaria on the Thai-Myanmar Border (2003\u20132013): the role of parasite genetic factors","volume":"63","author":"Phyo","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2018.03.026_b0110","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/AAC.00675-10","article-title":"4-Aminoquinolines active against chloroquine-resistant Plasmodium falciparum: basis of antiparasite activity and quantitative structure-activity relationship analyses","volume":"55","author":"Hocart","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2018.03.026_b0115","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.3544220","article-title":"Reversal of chloroquine resistance in Plasmodium falciparum by verapamil","volume":"235","author":"Martin","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2018.03.026_b0120","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1126\/science.3317830","article-title":"Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance","volume":"238","author":"Krogstad","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2018.03.026_b0125","article-title":"Imipramine induced complete reversal of chloroquine resistance in Plasmodium falciparum infections in Sudan","volume":"12","author":"Adam","year":"2004","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.bmcl.2018.03.026_b0130","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1128\/AAC.45.9.2655-2657.2001","article-title":"Structural analysis of chloroquine resistance reversal by imipramine analogs","volume":"45","author":"Bhattacharjee","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2018.03.026_b0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7883\/yoken1952.47.59","article-title":"In vitro reversal of chloroquine resistance with chlorpheniramine against African isolates of Plasmodium falciparum","volume":"47","author":"Basco","year":"1994","journal-title":"Japn J Med Sci Biol"},{"key":"10.1016\/j.bmcl.2018.03.026_b0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/00034983.1991.11812549","article-title":"Chloroquine-potentiating action of antihistaminics in Plasmodium falciparum in vitro","volume":"85","author":"Basco","year":"1991","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.bmcl.2018.03.026_b0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drup.2006.09.002","article-title":"Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum","volume":"9","author":"Van Schalkwyk","year":"2006","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.bmcl.2018.03.026_b0150","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1128\/AAC.00669-07","article-title":"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum","volume":"51","author":"Kelly","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2018.03.026_b0155","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1021\/jm060399n","article-title":"A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum","volume":"49","author":"Burgess","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2018.03.026_b0160","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1021\/jm1006484","article-title":"Synthesis, structure-activity relationship, and mode-of-action studies of antimalarial reversed chloroquine compounds","volume":"53","author":"Burgess","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2018.03.026_b0165","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2174\/156802612799362968","article-title":"Reversed chloroquine molecules as a strategy to overcome resistance in malaria","volume":"12","author":"Peyton","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmcl.2018.03.026_b0170","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1016\/j.bmcl.2014.09.088","article-title":"Pentacycloundecylamines and conjugates thereof as chemosensitizers and reversed chloroquine agents","volume":"24","author":"Joubert","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.03.026_b0175","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1021\/jm900972u","article-title":"Reversal agent and linker variants of reversed chloroquines: activities against Plasmodium falciparum","volume":"53","author":"Andrews","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2018.03.026_b0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/jm990437l","article-title":"Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of \u03b2-hematin formation, and antiplasmodial activity","volume":"43","author":"Egan","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2018.03.026_b0185","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.bmcl.2016.01.052","article-title":"Polycyclic amines as chloroquine resistance modulating agents in Plasmodium falciparum","volume":"26","author":"Joubert","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.03.026_b0190","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1039\/C4MD00244J","article-title":"Adamantane amine derivatives as dual acting NMDA receptor and voltage-gated calcium channel inhibitors for neuroprotection","volume":"5","author":"Kadernani","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmcl.2018.03.026_b0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-59745-529-9_2","article-title":"Memantine as an example of a fast, voltage-dependent, open channel N-methyl-D-aspartate receptor blocker","volume":"403","author":"Parsons","year":"2007","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmcl.2018.03.026_b0200","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0149-7634(96)00037-1","article-title":"Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents \u2013 preclinical studies","volume":"21","author":"Danysz","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bmcl.2018.03.026_b0205","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/0006-2952(93)90264-W","article-title":"Plasmodium falciparum: effects of amantadine, an antiviral, on chloroquine-resistant and -sensitive parasites in vitro and its influence on chloroquine activity","volume":"45","author":"Evans","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2018.03.026_b0210","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1021\/jm0108707","article-title":"Novel short chain chloroquine analogues retain activity against chloroquine resistant K1 Plasmodium falciparum","volume":"45","author":"Stocks","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2018.03.026_b0215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/0250-474X.70471","article-title":"Chloroquine-induced pruritus","volume":"72","author":"Aghahowa","year":"2010","journal-title":"Indian J Pharm Sci"},{"key":"10.1016\/j.bmcl.2018.03.026_b0220","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF00558141","article-title":"Epidemology of antimalarial-induced pruritus in Africans","volume":"37","author":"Ajayi","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bmcl.2018.03.026_b0225","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1128\/AAC.40.8.1846","article-title":"4-Aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum","volume":"40","author":"Ridley","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2018.03.026_b0230","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1016\/j.bmcl.2011.07.028","article-title":"N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (\u03c3) receptor ligands","volume":"21","author":"Banister","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.03.026_b0235","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1021\/jo01290a029","article-title":"Oxidation of 7-(hydroxymethyl)bicyclo [3.3.1]nonan-3-ol. Convenient synthesis of bicyclo[3.3.1]nonane-3,7-dione","volume":"45","author":"Zalikowski","year":"1980","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2018.03.026_b0240","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1021\/jm701478a","article-title":"4-N-, 4-S-, and 4-O-Chloroquine analogues: influence of side chain length and quinolyl nitrogen pKa on activity against chloroquine resistant malaria","volume":"51","author":"Natarajan","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2018.03.026_b0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.bmcl.2018.03.026_b0250","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/bjc.1987.190","article-title":"A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity","volume":"56","author":"Twentyman","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bmcl.2018.03.026_b0255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.1993.48.205","article-title":"Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia","volume":"48","author":"Makler","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.bmcl.2018.03.026_b0260","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/S0036-46652010000400006","article-title":"In vitro antimalarial activity and cytotoxicity of some selected Cuban medicinal plants","volume":"52","author":"Vald\u00e9s","year":"2010","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"10.1016\/j.bmcl.2018.03.026_b0265","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jep.2007.08.012","article-title":"Are West African plants a source of future antimalarial drugs?","volume":"114","author":"Soh","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmcl.2018.03.026_b0270","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1021\/jm020858u","article-title":"Structure activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position","volume":"45","author":"Kaschula","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2018.03.026_b0275","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1021\/cr60225a003","article-title":"The chemistry of imines","volume":"63","author":"Layer","year":"1963","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2018.03.026_b0280","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/cmdc.201100559","article-title":"Polycyclic cage structures as lipophilic scaffolds for neuroactive drugs","volume":"7","author":"Joubert","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2018.03.026_b0285","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1242\/jcs.02795","article-title":"The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance","volume":"119","author":"Hayward","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bmcl.2018.03.026_b0290","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4269\/ajtmh.1996.55.579","article-title":"Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro","volume":"55","author":"De","year":"1996","journal-title":"Am J Trop Med Hyg"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18302051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18302051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:21:45Z","timestamp":1760772105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X18302051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0960894X18302051"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.03.026","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adamantane amine-linked chloroquinoline derivatives as chloroquine resistance modulating agents in Plasmodium falciparum","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}